Your browser doesn't support javascript.
loading
Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.
Béreau, Matthieu; Fleury, Vanessa; Bouthour, Walid; Castrioto, Anna; Lhommée, Eugénie; Krack, Paul.
Afiliação
  • Béreau M; Service de neurologie, université de Franche-Comté, CHRU de Besançon, 25030 Besançon, France; Unité extrapyramidale, département des neurosciences cliniques, HUG, faculté de médecine, université de Genève, 1205 Genève, Suisse. Electronic address: mbereau@chu-besancon.fr.
  • Fleury V; Unité extrapyramidale, département des neurosciences cliniques, HUG, faculté de médecine, université de Genève, 1205 Genève, Suisse.
  • Bouthour W; Unité extrapyramidale, département des neurosciences cliniques, HUG, faculté de médecine, université de Genève, 1205 Genève, Suisse.
  • Castrioto A; Unité des mouvements anormaux, département de neurologie et de psychiatrie, université Grenoble-Alpes, CHU de Grenoble, 38043 Grenoble, France.
  • Lhommée E; Unité des mouvements anormaux, département de neurologie et de psychiatrie, université Grenoble-Alpes, CHU de Grenoble, 38043 Grenoble, France.
  • Krack P; Unité extrapyramidale, département des neurosciences cliniques, HUG, faculté de médecine, université de Genève, 1205 Genève, Suisse.
Rev Neurol (Paris) ; 174(9): 653-663, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30224159
ABSTRACT
Impulse control disorders (ICDs) and other related behaviors, such as punding and dopamine dysregulation syndrome, are frequent yet underrecognized non-motor complications of dopamine replacement therapy (DRT) in Parkinson's disease (PD); they can also have a major negative impact on quality of life. They result from complex interactions between a given individual's predispositions, non-physiological dopaminergic stimulation and PD pathology. Also, sensitization of the mesocorticolimbic pathway, reflected by the psychotropic effects of dopaminergic treatment, plays a crucial role in the emergence of these addictive behaviors. While early detection of changes in behavior, less use of dopamine agonists (DA) that have a relative selectivity for mesocorticolimbic dopamine receptors, and fractionation of levodopa dosages to avoid non-physiological pulsatile stimulation of dopamine receptors are key strategies in the management of this hyperdopaminergic behavioral spectrum, other complementary approaches are also addressed in this review.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Dopaminérgicos / Dopamina / Transtornos Mentais Tipo de estudo: Diagnostic_studies / Etiology_studies / Screening_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Dopaminérgicos / Dopamina / Transtornos Mentais Tipo de estudo: Diagnostic_studies / Etiology_studies / Screening_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2018 Tipo de documento: Article